spacer gif spacer gif spacer gif spacer gif spacer gif
 QUICK SEARCH:   [advanced]


spacer gif
     Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents    


This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Neveu, M. J.
Right arrow Articles by Pitot, H. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Neveu, M. J.
Right arrow Articles by Pitot, H. C.

Journal of Cell Science, Vol 107, Issue 1 83-95, Copyright © 1994 by Company of Biologists


JOURNAL ARTICLES

Multiple mechanisms are responsible for altered expression of gap junction genes during oncogenesis in rat liver

MJ Neveu, JR Hully, KL Babcock, EL Hertzberg, BJ Nicholson, DL Paul and HC Pitot
McArdle Laboratory for Cancer Research, University of Wisconsin, Madison.

Although several abnormalities in gap junction (GJ) structure and/or function have been described in neoplasms, the molecular mechanisms responsible for many of the alterations remain unknown. The identification of a family of GJ proteins, termed connexins, prompted this study of connexin32 (Cx32), connexin26 (Cx26) and connexin43 (Cx43) expression during rat hepatocarcinogenesis. Using antibody, cDNA and cRNA probes, we investigated connexin mRNA and protein expression in preneoplastic and neoplastic rat livers. In normal liver, Cx32 is expressed in hepatocytes throughout the hepatic acinus, Cx26 is restricted to periportal hepatocytes, and Cx43 is expressed by mesothelial cells forming Glisson's capsule. Most preneoplastic altered hepatic foci generated by diethylnitrosamine (DEN) initiation and either phenobarbital (PB) or 2,3,7,8-dichlorodibenzo-p-dioxin (TCDD) promotion exhibited decreased Cx32 or increased Cx26 staining. Foci from either protocol failed to display Cx43 immunoreactivity. In the majority of PB-promoted foci, Cx32 immunoreactivity decreased independently of changes in mRNA abundance. Continuous thymidine labeling, following cessation of PB promotion, showed that downregulation of Cx32 staining is reversible in foci that are promoter-dependent for growth, but irreversible in lesions that are promoter-independent for growth. Hepatic neoplasms from rats initiated with DEN and promoted with PB or TCDD also displayed modified connexin expression. While all 24 neoplasms studied were deficient in normal punctate Cx32 and Cx26 staining, altered cellular localization of these proteins was apparent in some tumors. Immunoblotting of crude tissue extracts revealed that neoplasms with disordered Cx32 staining showed immunoreactive bands with altered electrophoretic mobility. These observations show that hepatomas may downregulate Cx32 expression through changes in the primary structure of Cx32 or by post-translational modifications. Northern blotting of total tumor mRNAs failed to demonstrate consistent changes in the abundance of Cx32, Cx26 or Cx43 transcripts. Some tumors expressed steady-state transcripts without observable immunoreactivity, indicating that some hepatomas downregulate connexin immunoreactivity independently of mRNA abundance. Increased levels of Cx43 mRNA and protein were found in several neoplasms, but immunostaining was always localized to nonparenchymal cells. Areas of bile duct proliferation and cholangiomas displayed Cx43 staining, whereas, cholangiocarcinomas were deficient in immunoreactivity. These findings show that alterations in the expression of connexins, by either downregulation or differential induction, represent common modifications during hepatocarcinogenesis. Although our results imply that connexins represent useful markers for the boundary between tumor promotion and progression, preneoplastic and neoplastic rat hepatocytes fail to use a common mechanism to modify connexin expression.


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
F. Marongiu, S. Doratiotto, S. Montisci, P. Pani, and E. Laconi
Liver Repopulation and Carcinogenesis: Two Sides of the Same Coin?
Am. J. Pathol., April 1, 2008; 172(4): 857 - 864.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H. Lahlou, M. Fanjul, L. Pradayrol, C. Susini, and S. Pyronnet
Restoration of Functional Gap Junctions through Internal Ribosome Entry Site-Dependent Synthesis of Endogenous Connexins in Density-Inhibited Cancer Cells
Mol. Cell. Biol., May 15, 2005; 25(10): 4034 - 4045.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
E. Leithe, V. Cruciani, T. Sanner, S.-O. Mikalsen, and E. Rivedal
Recovery of gap junctional intercellular communication after phorbol ester treatment requires proteasomal degradation of protein kinase C
Carcinogenesis, July 1, 2003; 24(7): 1239 - 1245.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Viluksela, Y. Bager, J. T. Tuomisto, G. Scheu, M. Unkila, R. Pohjanvirta, S. Flodström, V.-M. Kosma, J. Mäki-Paakkanen, T. Vartiainen, et al.
Liver Tumor-promoting Activity of 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) in TCDD-sensitive and TCDD-resistant Rat Strains
Cancer Res., December 1, 2000; 60(24): 6911 - 6920.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
A. Low-Baselli, W. W. Huber, M. Kafer, K. Bukowska, R. Schulte-Hermann, and B. Grasl-Kraupp
Failure to demonstrate chemoprevention by the monoterpene perillyl alcohol during early rat hepatocarcinogenesis: a cautionary note
Carcinogenesis, October 1, 2000; 21(10): 1869 - 1877.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
S.-H. Jeong, S. S. M. Habeebu, and C. D. Klaassen
Cadmium Decreases Gap Junctional Intercellular Communication in Mouse Liver
Toxicol. Sci., September 1, 2000; 57(1): 156 - 166.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
O. Moennikes, A. Buchmann, A. Romualdi, T. Ott, J. Werringloer, K. Willecke, and M. Schwarz
Lack of Phenobarbital-mediated Promotion of Hepatocarcinogenesis in Connexin32-Null Mice
Cancer Res., September 1, 2000; 60(18): 5087 - 5091.
[Abstract] [Full Text]


Home page
Toxicol PatholHome page
T. Shoda, H. Onodera, M. Takeda, C. Uneyama, T. Imazawa, K. Takegawa, K. Yasuhara, T. Watanabe, M. Hirose, and K. Mitsumori
Liver Tumor Promoting Effects of Fenbendazole in Rats
Toxicol Pathol, September 1, 1999; 27(5): 553 - 562.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
O. Moennikes, A. Buchmann, T. Ott, K. Willecke1, and M. Schwarz2
The effect of connexin32 null mutation on hepatocarcinogenesis in different mouse strains
Carcinogenesis, July 1, 1999; 20(7): 1379 - 1382.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. P. Piechocki, R. D. Burk, and R. J. Ruch
Regulation of connexin32 and connexin43 gene expression by DNA methylation in rat liver cells
Carcinogenesis, March 1, 1999; 20(3): 401 - 406.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. G. Bevans, M. Kordel, S. K. Rhee, and A. L. Harris
Isoform Composition of Connexin Channels Determines Selectivity among Second Messengers and Uncharged Molecules
J. Biol. Chem., January 30, 1998; 273(5): 2808 - 2816.
[Abstract] [Full Text] [PDF]




© The Company of Biologists Ltd 1994